WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New ATCvet codes 2018

 Updates included in the ATCvet Index valid from 2018.

ATC codeATCvet level name
QA02BX14rebamipide
QA06AX07plecanatide
QA07AA95avilamycin
QA10AE54insulin glargine and lixisenatide
QA10BD22metformin and evogliptin
QA10BH07evogliptin
QA10BJ06semaglutide
QA11CC55colecalciferol, combinations
QA16AB15velmanase alfa
QA16AB16idursulfase beta
QA16AB17cerliponase alfa
QA16AB18vestronidase alfa
QA16AX14migalastat
QB02BX06emicizumab
QB05AA91 hemoglobin betafumaril (bovine)
QC09BX03ramipril, amlodipine and hydrochlorothiazide
QC09DA10fimasartan and diuretics
QC10BX13rosuvastatin, perindopril and indapamide
QC10BX14rosuvastatin, amlodipine and perindopril
QC10BX15atorvastatin and perindopril
QD01AE24tavaborole
QD06AX14ozenoxacin
QD11AH05dupilumab
QI01AD16avian herpes virus (marek’s disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus
/paramyxovirus
QI01AL07newcastle disease virus
/paramyxovirus + salmonella + pasteurella
QI02AE05mycoplasma
QI03AD01peste de petits ruminants (PPR)
QJ05AP56sofosbuvir, velpatasvir and voxilaprevir
QJ05AR20emtricitabine, tenofovir alafenamide and bictegravir
QJ05AR21dolutegravir and rilpivirine
QJ05AR22emtricitabine, tenofovir alafenamide, darunavir and cobicistat
QL01BB90 rabacfosadine
QL01XC27olaratumab
QL01XC28durvalumab
QL01XC29ermekumab
QL01XD07padeliporfin
QL01XE41binimetinib
QL01XE42ribociclib
QL01XE43brigatinib
QL01XX54niraparib
QL01XX55rucaparib
QL01XX56etirinotecan pegol
QL01XX57plitidepsin
QL03AA17pegteograstim
QL03AB15ropeginterferon alfa-2b
QL04AC15sirukumab
QL04AC16guselkumab
QM01AH07polmacoxib
QM05BX06romosozumab
QM09AX06eteplirsen
QM09AX07nusinersen
QN01BA53tetracaine, combinations
QN02AA53hydromorphone and naloxone
QN02AA56oxycodone and naltrexone
QN02CX07erenumab
QN04BX04opicapone
QN05BX05Lavandulae aetheroleum
QN05CM19suvorexant
QN07BA04cytisine
QP51AJ51 toltrazuril, combinations
QR03AL08vilanterol, umeclidinium bromide and fluticasone furoate
QR03AL09formoterol, glycopyrronium bromide and beclometasone
QR03DA12mepyramine theophyllinacetate
QR03DX10benralizumab
QR07AX31ivacaftor and tezacaftor
QS01EX05netarsudil
QS01XA24cenegermin
QS01XA25lifitegrast
QS02BA99 corticosteroids, combinations
QV03AB38andexanet alfa
QV03AE10sodium zirconium cyclosilicate
QV10XX04lutetium (177Lu) oxodotreotide

Last updated: 2017-12-12